-
S276349-500μgStore at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.
-
R346531-5mgA selective D1 dopamine receptor agonist.
-
-
-
-
T650138-100mg(R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H + /K + -ATPase inhibitor with an IC 50 of 98 nM of canine kidney Na + /K + -ATPase. (R)-Tegoprazan has the potential for gastrointestinal diseases research.Form:Solid.
-
T650138-10mg(R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H + /K + -ATPase inhibitor with an IC 50 of 98 nM of canine kidney Na + /K + -ATPase. (R)-Tegoprazan has the potential for gastrointestinal diseases research.Form:Solid.
-
T650138-25mg(R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H + /K + -ATPase inhibitor with an IC 50 of 98 nM of canine kidney Na + /K + -ATPase. (R)-Tegoprazan has the potential for gastrointestinal diseases research.Form:Solid.
-
T650138-50mg(R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H + /K + -ATPase inhibitor with an IC 50 of 98 nM of canine kidney Na + /K + -ATPase. (R)-Tegoprazan has the potential for gastrointestinal diseases research.Form:Solid.
-
T650138-5mg(R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H + /K + -ATPase inhibitor with an IC 50 of 98 nM of canine kidney Na + /K + -ATPase. (R)-Tegoprazan has the potential for gastrointestinal diseases research.Form:Solid.
-
T646849-10mg(R)-Terazosin is an active R-enantiomer of Terazosin. (R)-Terazosin is a potent α1-adrenoceptor antagonist with K i values of 6.51 nM, 1.01 nM and 1.97 nM for α1a , α1b and α1d-adrenoceptor , respectivelyIn Vitro(R)-Terazosin is low affinity for
-
T646849-50mg(R)-Terazosin is an active R-enantiomer of Terazosin. (R)-Terazosin is a potent α1-adrenoceptor antagonist with K i values of 6.51 nM, 1.01 nM and 1.97 nM for α1a , α1b and α1d-adrenoceptor , respectivelyIn Vitro(R)-Terazosin is low affinity for